Biosimilars Market 2025-2033: Enhancing Cost-Effective Healthcare
Currently, monoclonal antibodies lead the pack in sales within the biosimilar market, but recombinant hormones, such as insulin and erythropoietin, are experiencing the fastest growth rates.In terms of geography, Europe and North America are at the forefront of biosimilar adoption.